Notice Number: NOT-CA-14-019

Key Dates
Release Date: January 2, 2014

Issued by
National Cancer Institute (NCI)

Purpose

The purpose of this Notice is to inform potential applicants that the National Cancer Institute (NCI) is participating in RFA-HL-14-031, entitled "Development of an NIH BD2K Data Discovery Index Coordination Consortium (U24)."

Part 1. Overview Information, the Components of Participating Organizations section has been revised as shown below to include the NCI:

Components of Participating Organizations
National Heart, Lung, and Blood Institute (NHLBI)
National Human Genome Research Institute (NHGRI)
National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
National Institute on Deafness and Other Communication Disorders (NIDCD)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
National Institute on Drug Abuse (NIDA)
National Institute of Environmental Health Sciences (NIEHS)
National Institute of Neurological Disorders and Stroke (NINDS)
National Institute on Minority Health and Health Disparities (NIMHD)
National Library of Medicine (NLM)
Office of Strategic Coordination (Common Fund)
National Cancer Institute (NCI)

Part 1. Overview Information, the Catalog of Federal Domestic Assistance (CFDA) Number(s) has been revised as shown below to include the appropriate number for the NCI, which is 93.393:

Catalog of Federal Domestic Assistance (CFDA) Number(s)
93.837; 93.172; 93.855; 93.856; 93.273; 93.846; 93.847; 93.310; 93.279; 93.113; 93.173; 93.307; 93.853; 93.879; 93.286; 93.393

Inquiries

Please direct all inquiries to:

Michelle Dunn, Ph.D.
National Cancer Institute (NCI)
Telephone: 240-276-6881
Email: dunnm3@mail.nih.gov